Analyze Diet

Topic:Disease Prevention

Disease prevention in horses encompasses strategies and practices aimed at minimizing the occurrence and spread of infectious and non-infectious diseases within equine populations. These practices include vaccination programs, biosecurity measures, and regular health monitoring. Vaccination helps to stimulate the horse's immune system to protect against specific pathogens, while biosecurity measures, such as quarantine and sanitation, reduce the risk of disease transmission. Regular health monitoring, including physical examinations and diagnostic testing, aids in early detection and management of potential health issues. This page compiles peer-reviewed research studies and scholarly articles that explore various methods and their effectiveness in preventing diseases in horses, as well as the development and implementation of prevention programs in different equine settings.
Evaluation of the effects of footwear hygiene protocols on nonspecific bacterial contamination of floor surfaces in an equine hospital.
Journal of the American Veterinary Medical Association    April 4, 2006   Volume 228, Issue 7 1068-1073 doi: 10.2460/javma.228.7.1068
Stockton KA, Morley PS, Hyatt DR, Burgess BA, Patterson G, Dunowska M, Lee DE.To evaluate the effects of footwear hygiene protocols on bacterial contamination of floor surfaces in an equine hospital. Methods: Field trial. Methods: Footwear hygiene protocols evaluated included use of rubber overboots with footbaths and footmats containing a quaternary ammonium disinfectant, rubber overboots with footbaths and footmats containing a peroxygen disinfectant, and no restrictions on footwear type but mandatory use of footbaths and footmats containing a peroxygen disinfectant. Nonspecific aerobic bacterial counts were determined via 2 procedures for sample collection and bacter...
Mortality of Swedish horses with complete life insurance between 1997 and 2000: variations with sex, age, breed and diagnosis.
The Veterinary record    March 28, 2006   Volume 158, Issue 12 397-406 doi: 10.1136/vr.158.12.397
Egenvall A, Penell JC, Bonnett BN, Olson P, Pringle J.The aim of this study was to evaluate the potential usefulness of the database maintained by the Swedish insurance company Agria for providing mortality statistics on Swedish horses. Mortality statistics (incidence rates and survival) were calculated, both crudely and stratified by sex, age, breed, breed group and diagnosis, for the horses with complete life insurance, which covers most health problems. The total mortality was 415 (95 per cent confidence interval [CI] 399 to 432) deaths per 10,000 horse-years at risk, and the diagnostic mortality, including only deaths with an assigned diagnos...
Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
Veterinary immunology and immunopathology    March 23, 2006   Volume 111, Issue 1-2 81-95 doi: 10.1016/j.vetimm.2006.01.011
Soboll G, Hussey SB, Whalley JM, Allen GP, Koen MT, Santucci N, Fraser DG, Macklin MD, Swain WF, Lunn DP.Equine herpesvirus-1 (EHV-1) is the cause of serious disease with high economic impact on the horse industry, as outbreaks of EHV-1 disease occur every year despite the frequent use of vaccines. Cytotoxic T-lymphocytes (CTLs) are important for protection from primary and reactivating latent EHV-1 infection. DNA vaccination is a powerful technique for stimulating CTLs, and the aim of this study was to assess antibody and cellular immune responses and protection resulting from DNA vaccination of ponies with combinations of EHV-1 genes. Fifteen ponies were divided into three groups of five ponies...
Questions reliability of fecal egg counts in equine study.
Journal of the American Veterinary Medical Association    March 17, 2006   Volume 228, Issue 5 688-689 
Bradley RE.No abstract available
Epidemiology of equine performance wastage: importance of analysing facts and implementing their message in management.
Equine veterinary journal    March 16, 2006   Volume 38, Issue 2 98-100 doi: 10.2746/042516406776563279
Parkin TD, Rossdale PD.No abstract available
[MRSA–not just a problem in hospitals].
Medizinische Monatsschrift fur Pharmazeuten    March 2, 2006   Volume 29, Issue 2 45 
Heinzl S.No abstract available
Vaccination against equine influenza: quid novi?
Vaccine    February 28, 2006   Volume 24, Issue 19 4047-4061 doi: 10.1016/j.vaccine.2006.02.030
Paillot R, Hannant D, Kydd JH, Daly JM.Equine influenza virus is a leading cause of respiratory disease in the horse. Equine influenza vaccines containing inactivated virus were first developed in the 1960s. Despite their intensive use, equine influenza outbreaks still continue to occur and therefore new strategies of vaccination are necessary to improve vaccine efficacy. Numerous methods of vaccination have been evaluated and commercialised in the horse, the most recent being the cold-adapted influenza virus and poxvirus-based vaccines. As a large animal model, the horse is also a useful species in which to evaluate the potential ...
Mucosal and systemic adjuvant activity of alphavirus replicon particles.
Proceedings of the National Academy of Sciences of the United States of America    February 27, 2006   Volume 103, Issue 10 3722-3727 doi: 10.1073/pnas.0600287103
Thompson JM, Whitmore AC, Konopka JL, Collier ML, Richmond EM, Davis NL, Staats HF, Johnston RE.Vaccination represents the most effective control measure in the fight against infectious diseases. Local mucosal immune responses are critical for protection from, and resolution of, infection by numerous mucosal pathogens. Antigen processing across mucosal surfaces is the natural route by which mucosal immunity is generated, as peripheral antigen delivery typically fails to induce mucosal immune responses. However, we demonstrate in this article that mucosal immune responses are evident at multiple mucosal surfaces after parenteral delivery of Venezuelan equine encephalitis virus replicon pa...
Fell Pony syndrome in a pony in North America.
Journal of veterinary internal medicine    February 25, 2006   Volume 20, Issue 1 198-203 doi: 10.1892/0891-6640(2006)20[198:fpsiap]2.0.co;2
Gardner RB, Hart KA, Stokol T, Divers TJ, Flaminio MJ.A 5-week-old Fell Pony colt was examined for fever, lethargy, and anemia. The colt had been lethargic for 1 week before examination, had continued to nurse, had a temperature of 104°F (40°C), and was treated with ceftiofur (5 mg/kg IM q12h). Approximately 36 hours before examination, the colt developed watery diarrhea. Blood work performed by the referring veterinarian on the day of admission revealed a PCV of 10%.
Protective effect of vaccination with recombinant proteins from Streptococcus equi subspecies equi in a strangles model in the mouse.
Vaccine    February 23, 2006   Volume 24, Issue 19 4144-4151 doi: 10.1016/j.vaccine.2006.02.016
Flock M, Karlström A, Lannergård J, Guss B, Flock JI.A mouse model resembling Streptococcus equi subspecies equi infection in the horse, strangles, was used to assess the protective effect of vaccination with selected recombinant proteins from S. equi subsp. equi. After challenge the infection was monitored by weight loss and by nasal colonisation with S. equi subsp. equi. Vaccination with a collagen-binding protein (CNE) and a collagen-like protein (SclC) resulted in protective antibodies, whereas a novel fibronectin-binding protein (FNEB) did not. Co-administration of CNE with EAG, a poorly immunogenic alpha2-macroglobulin-, albumin- and immun...
Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
Veterinary immunology and immunopathology    February 14, 2006   Volume 111, Issue 1-2 67-80 doi: 10.1016/j.vetimm.2006.01.010
Holmes MA, Townsend HG, Kohler AK, Hussey S, Breathnach C, Barnett C, Holland R, Lunn DP.Horses are commonly vaccinated to protect against pathogens which are responsible for diseases which are endemic within the general horse population, such as equine influenza virus (EIV) and equine herpesvirus-1 (EHV-1), and against a variety of diseases which are less common but which lead to greater morbidity and mortality, such as eastern equine encephalomyelitis virus (EEE) and tetanus. This study consisted of two trials which investigated the antigenicity of commercially available vaccines licensed in the USA to protect against EIV, EHV-1 respiratory disease, EHV-1 abortion, EEE and tetan...
Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
Veterinary immunology and immunopathology    February 13, 2006   Volume 111, Issue 1-2 59-66 doi: 10.1016/j.vetimm.2006.01.009
Weerasinghe CU, Learmonth GS, Gilkerson JR, Foote CE, Wellington JE, Whalley JM.The envelope glycoprotein D of EHV-1 (EHV-1 gD) is essential for virus infectivity and entry of virus into cells and is a potent inducer of virus-neutralizing antibody. In this study, truncated EHV-1 gD (gDt) was expressed with a C-terminal hexahistidine tag in E. coli using a pET vector. Western blot analysis using an anti-gD monoclonal antibody demonstrated the presence of gDt bands at 37.5, 36, 29.5 and 28 kDa. The immunogenicity and protective efficacy of partially purified gDt was compared with gD expressed in insect cells by a recombinant baculovirus (Bac gD) using a BALB/c mouse model o...
Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
Vaccine    February 13, 2006   Volume 24, Issue 17 3636-3645 doi: 10.1016/j.vaccine.2006.01.062
Goodman LB, Wagner B, Flaminio MJ, Sussman KH, Metzger SM, Holland R, Osterrieder N.Equine herpesvirus type 1 (EHV-1) is a ubiquitous alphaherpesvirus of horses which causes rhinopneumonitis, abortion and myeloencephalopathy. To test the efficacy of commercial vaccines in protection against neurological EHV-1 challenge, groups of five horses were immunized with modified-live virus or an inactivated vaccine, or received placebo. Horses were challenged by aerosol with a recent virus isolate obtained from a case of paralytic EHV-1. The duration of fever decreased significantly in the modified-live virus vaccine group. Three animals in each of the inactivate and control groups sh...
Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?
Expert review of vaccines    February 3, 2006   Volume 5, Issue 1 119-131 doi: 10.1586/14760584.5.1.119
Rosas CT, Goodman LB, von Einem J, Osterrieder N.Infections of horses with equine herpesvirus type 1 (EHV-1) have garnered new attention over the last few years. Devastating outbreaks occurring worldwide, primarily of the neurologic form of the disease, have resulted in a reassessment of the control strategies, and particularly the prophylactic measures, that are necessary to keep the infection and spread of disease in check. Most of the available EHV-1 vaccines are based on preparations of inactivated virus, which are applied monovalently for prevention of EHV-1-caused abortion in pregnant mares or as part of multivalent vaccines to prevent...
New diseases and increased risk of diseases in companion animals and horses due to transport.
Acta veterinaria Scandinavica. Supplementum    January 25, 2006   Volume 100 19-25 
Englund L, Pringle J.Dogs and horses are transported within the European Union for a number of reasons. The transport per se may cause physical problems, exemplified by hyperthermia in dogs and pleuropneumonia in horses, and the stress may reactivate latent infections such as canine herpesvirus-1 and equine herpesvirus-1. Preventive treatments are vital to protect dogs from ticks and mosquitoes transmitting their potentially lethal infectious agents, such as Leishmania donovani infantum, Babesia canis, Ehrlichia canis, and Dirofilaria immitis. However, records show that the travelling dogs are not fully protected ...
Pyrantel pamoate resistance in horses receiving daily administration of pyrantel tartrate.
Journal of the American Veterinary Medical Association    January 24, 2006   Volume 228, Issue 1 101-103 doi: 10.2460/javma.228.1.101
Brazik EL, Luquire JT, Little D.16 horses treated daily with pyrantel tartrate (2.64 mg/kg [1.2 mg/lb], PO) as part of a prophylactic anthelmintic program. Results: Fecal worm egg counts (FWECs) were obtained on all 16 horses. Mean FWEC was 478 eggs/g (epg; range, 0 to 4,075 epg). Three of the 16 horses were responsible for 85% of the total fecal egg output for the herd on the day of sampling. Six horses had FWECs < 200 epg. Three horses that had arrived within 4 months of the sampling date had FWECs 100 epg (9 horses) were treated with pyrantel pamoate (6.6 mg/kg [3 mg/lb], PO), and 14 days later, the FWEC was repeated....
[Scabies in business].
Tijdschrift voor diergeneeskunde    December 21, 2005   Volume 130, Issue 23 733 
Boissevain I.No abstract available
Antibody responses of mares to prepartum vaccination with Clostridium perfringens bacterin and beta2 toxin.
The Veterinary record    December 20, 2005   Volume 157, Issue 25 810-812 doi: 10.1136/vr.157.25.810
Timoney JF, Hartmann M, Fallon L, Fallon E, Walker J.No abstract available
Laparoscopic closure of the nephrosplenic space for prevention of recurrent nephrosplenic entrapment of the ascending colon.
Veterinary surgery : VS    December 14, 2005   Volume 34, Issue 6 642-645 doi: 10.1111/j.1532-950X.2005.00099.x
Farstvedt E, Hendrickson D.To evaluate outcome after laparoscopic closure of the nephrosplenic space in horses that had previous nephrosplenic entrapment of ascending colon (left dorsal displacement of the left colon; LDDLC). Methods: Retrospective study. Methods: Horses that had previous LDDLC. Methods: Medical records of horses that had LDDLC and subsequent laparoscopic nephrosplenic space closure between 2002 and 2004 were retrieved. Follow-up information was obtained by telephone interview of owners. Preoperative versus postoperative comparisons were: incidence of LDDLC, incidence of colic signs, and incidence of ve...
Evaluation of five commercially available assays and measurement of serum total protein concentration via refractometry for the diagnosis of failure of passive transfer of immunity in foals.
Journal of the American Veterinary Medical Association    November 30, 2005   Volume 227, Issue 10 1640-1645 doi: 10.2460/javma.2005.227.1640
Davis R, Giguère S.To determine and compare sensitivity, specificity, accuracy, and predictive values of measurement of serum total protein concentration by refractometry as well as 5 commercially available kits for the diagnosis of failure of passive transfer (FPT) of immunity in foals. Methods: Prospective study. Methods: 65 foals with various medical problems and 35 clinically normal foals. Methods: IgG concentration in serum was assessed by use of zinc sulfate turbidity (assay C), glutaraldehyde coagulation (assay D), 2 semiquantitative immunoassays (assays F and G), and a quantitative immunoassay (assay H)....
Attempted eradication of methicillin-resistant staphylococcus aureus colonisation in horses on two farms.
Equine veterinary journal    November 22, 2005   Volume 37, Issue 6 510-514 doi: 10.2746/042516405775314835
Weese JS, Rousseau J.Methicillin-resistant Staphylococcus aureus (MRSA) is an emerging equine and zoonotic pathogen. Infection control protocols can be used to control MRSA in human hospitals, but measures to eradicate MRSA on horse farms have not been evaluated. Objective: To describe an MRSA eradication programme that was used to attempt to eliminate MRSA colonisation among horses and horse personnel on 2 equine farms. Methods: Active surveillance cultures and infection control protocols were implemented on 2 farms with endemic MRSA. Results: Active screening and strict implementation of infection control protoc...
MRSA: an emerging equine problem?
Equine veterinary journal    November 22, 2005   Volume 37, Issue 6 490-492 doi: 10.2746/042516405775314790
Slater JD.No abstract available
Colic–Some bright views on the horizon.
Veterinary journal (London, England : 1997)    October 24, 2005   Volume 172, Issue 1 6-7 doi: 10.1016/j.tvjl.2005.08.028
Nieto J.No abstract available
Strongyle egg shedding consistency in horses on farms using selective therapy in Denmark.
Veterinary parasitology    October 13, 2005   Volume 135, Issue 3-4 333-335 doi: 10.1016/j.vetpar.2005.09.010
Nielsen MK, Haaning N, Olsen SN.Knowledge of horses that shed the same number of strongyle eggs over time can lead to the optimization of parasite control strategies. This study evaluated shedding of strongyle eggs in 424 horses on 10 farms when a selective anthelmintic treatment regime was used over a 3-year period. Faecal egg counts were performed twice yearly, and horses exceeding 200 eggs per gram (EPG) of faeces were treated. The results are presented as probabilities of the egg count outcome, when two previous egg counts are known. A horse with no strongyle eggs detected in the two previous faecal examinations had an 8...
A single-chain fragment variable recombinant antibody against F5 fimbria of enterotoxigenic Escherichia coli inhibits agglutination of horse red blood cells induced by F5 protein.
Veterinary research communications    October 11, 2005   Volume 29, Issue 6 463-476 doi: 10.1007/s11259-005-1432-z
Bhaskaran S, Jay CM, Berghman LR, Wagner GG, Waghela SD.Bovine colibacillosis caused by enterotoxigenic Escherichia coli (ETEC) is a worldwide problem. Adhesion of ETEC to intestinal cell receptors mediated by the surface protein F5 fimbriae is the initial step in the establishment of colibacillosis. Prevention of ETEC F5(+) adhesion to enterocytes protects newborn calves against collibacillosis. On the enterocytes, the F5 fimbriae bind to a ganglioside that is also found on horse red blood cells. Thus, the presence of F5 fimbriae induces haemagglutination, which is useful as an indicator in a functional assay system. In this study, recombinant ant...
[Prediction of 137Cs accumulation in animal products in the territory of Semipalatinsk test site].
Radiatsionnaia biologiia, radioecologiia    October 8, 2005   Volume 45, Issue 4 480-487 
Spiridonov SI, Gontarenko IA, Mukusheva MK, Fesenko SV, Semioshkina NA.The paper describes mathematical models for 137Cs behavior in the organism of horses and sheep pasturing on the bording area to the testing area "Ground Zero" of the Semipalatinsk Test Site. The models are parameterized on the base of the data from an experiment with the breeds of animals now commonly encountered within the Semipalatinsk Test Site. The predictive calculations with the models devised have shown that 137Cs concentrations in milk of horses and sheep pasturingon the testing area to "Ground Zero" can exceed the adopted standards during a long period of time.
Replacement of the in vivo neutralisation test for efficacy demonstration of tetanus vaccines ad us. vet.
ALTEX    September 28, 2005   Volume 22, Issue 3 169-174 
Rosskopf U, Noeske K, Werner E.The bacterium Clostridium (C.) tetani is an ubiquitous pathogen. This anaerobic, gram-positive bacterium can form spores and can be found in the whole environment. It enters the body via injuries of the skin and wounds where it releases the neurotoxin "tetanospasmin" (= tetanus toxin). The animals most susceptible to tetanus infection are horses and sheep. Only active immunisation by tetanus vaccine provides effective protection against tetanus intoxication. The marketing authorisation requirements stipulate that efficacy of tetanus vaccines ad us. vet. must be demonstrated in all target anima...
[Equine strongyles. I. Development of anthelmintic resistance].
Schweizer Archiv fur Tierheilkunde    September 27, 2005   Volume 147, Issue 9 381-388 doi: 10.1024/0036-7281.147.9.381
Meier A, Hertzberg H.Small strongyles (cyathostomes) that are resistant against anthelmintics have become a major problem in equine medicine in the recent years. In many European countries benzimidazole-resistant cyathostomes are widespread and are now present in well over 50% of equine populations investigated. In contrast, resistance against ivermectin has not been reported despite its widespread use in the recent years. Optimising the frequency of treatments based on quantitative faecal monitoring is of great importance to preserve remaining anthelmintic efficacy.
[Equine strongyles II. Occurrence of anthelmintic resistance in Switzerland].
Schweizer Archiv fur Tierheilkunde    September 27, 2005   Volume 147, Issue 9 389-396 doi: 10.1024/0036-7281.147.9.389
Meier A, Hertzberg H.The occurrence of anthelmintic resistance in strongyles was investigated in 440 horses on 90 farms in Switzerland. The egg hatch assay suggested that benzimidazole (BZ)-resistance was present in 40 of 82 farms (49%). Faecal egg count reduction after pyrantel-treatment was above 96% in 14 of 15 farms. In the remaining farm the efficacy was only 80%. Ivermectin efficacy was investigated on 5 farms and the efficacy was recorded at 98-100%. Faecal cultures undertaken after treatment revealed almost exclusively larvae of the family Cyathostominae. Data about management practices, pasture hygiene an...
Evaluation of expected response to selection for orthopedic health and performance traits in Hanoverian Warmblood horses.
American journal of veterinary research    September 22, 2005   Volume 66, Issue 8 1371-1379 doi: 10.2460/ajvr.2005.66.1371
Stock KF, Distl O.To determine whether selection schemes accounting for orthopedic health traits were compatible with breeding progress in performance parameters in Hanoverian Warmblood horses. Methods: 5,928 horses. Methods: Relative breeding values (RBVs) were predicted for osseous fragments in fetlock (metacarpo- and metatarsophalangeal) and tarsal joints, deforming arthropathy in tarsal joints, and pathologic changes in distal sesamoid bones. Selection schemes were developed on the basis of total indices for radiographic findings (TIR), dressage (TID), and jumping (TIJ). Response to selection was traced ove...
1 62 63 64 65 66 119